David-Alexandre C. Gros

Insider Reports History

Entity
Individual
Location
220 Marlborough Street, #6, Boston, MA
Signature
/s/ Paul Little, as attorney-in-fact for David Alexandre C. Gros, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David-Alexandre C. Gros:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Option (right to buy) 517K Jun 13, 2024 Direct

Insider Reports Filed by David-Alexandre C. Gros

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELDN Eledon Pharmaceuticals, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Chief Executive Officer, Director
ELDN Eledon Pharmaceuticals, Inc. May 1, 2023 1 $0 4 May 2, 2023 Chief Executive Officer, Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2023 2 $0 4 Feb 2, 2023 Chief Executive Officer, Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 Chief Executive Officer, Director
ELDN Eledon Pharmaceuticals, Inc. Dec 20, 2021 1 $8.96K 4 Dec 21, 2021 Chief Executive Officer, Director
ELDN Eledon Pharmaceuticals, Inc. Aug 17, 2021 1 $24.8K 4 Aug 19, 2021 Chief Executive Officer, Director
ELDN Eledon Pharmaceuticals, Inc. Jun 9, 2021 1 $24K 4 Jun 10, 2021 Chief Executive Officer, Director